Percentage changes of all HR-pQCT indices between two groups
| Variables | No remission (n=27) | Remission (n=20) | p-value |
|---|---|---|---|
| Radius | |||
| Cortical vBMD | −0.19±1.76 | 0.63±3.19 | 0.269 |
| Trabecular vBMD | −2.41±7.30 | −3.06±7.22 | 0.765 |
| Cortical thickness | −1.12±4.51 | −0.11±3.43 | 0.407 |
| Cortical pore volume | 20.1±105 | −6.22±25.8 | 0.282 |
| Cortical porosity | 19.7±95.0 | −6.62±25.9 | 0.236 |
| Trabecular number | −2.21±8.34 | −0.55±7.31 | 0.483 |
| Trabecular thickness | 0.21±2.28 | −0.51±1.50 | 0.227 |
| Trabecular separation | 2.87±8.42 | 1.21±6.90 | 0.475 |
| Tibia | |||
| Cortical vBMD | −1.12±3.07 | −0.90±1.58 | 0.773 |
| Trabecular vBMD | −0.13±2.69 | 0.11±1.57 | 0.718 |
| Cortical thickness | −0.34±3.49 | 0.39±2.51 | 0.432 |
| Cortical pore volume | 6.27±17.28 | 5.05±11.6 | 0.785 |
| Cortical porosity | 7.89±18.5 | 4.95±12.4 | 0.542 |
| Trabecular number | 2.20±7.71 | 1.72±8.85 | 0.843 |
| Trabecular thickness | −0.58±1.80 | −0.24±1.47 | 0.494 |
| Trabecular separation | −1.37±7.29 | −0.92±8.89 | 0.847 |
RA, rheumatoid arthritis; CCP, cyclic citrullinated peptide; MMP-3, matrix metalloproteinase-3; DAS28-CRP, disease activity score 28 with C-reactive protein; mHAQ, modified Health Assessment Questionnaire; GC, glucocorticoid.